Bicardia Pharmaceuticals Private Limited
About Bicardia Pharmaceuticals Private Limited
Data last updated:
Bicardia Pharmaceuticals Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24304UP2019PTC123940. Its GSTIN is 05AAICB7733J1ZI (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rachna Yadav and Avdhesh Kumar Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Beena Devi W/O Dharampal Singh Yadav Krishna Vihar Colony Bhoola Road, Meerut, Uttar Pradesh, India – 250002.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.51 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹2.37 Lakh (net margin 1.6%) and EBITDA of ₹3.28 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
Company details
Contact details
Bicardia Pharmaceuticals Private Limited's registered office is in Meerut, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Beena Devi W/O Dharampal Singh Yadav Krishna Vihar Colony Bhoola Road, Meerut, Uttar Pradesh, India – 250002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bicardia Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bicardia Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bicardia Pharmaceuticals Private Limited, buy the company report.
Financials of Bicardia Pharmaceuticals Private Limited
FY 2025 filings availableBicardia Pharmaceuticals Private Limited reported revenue of ₹1.51 Cr (up 45% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over three years, including 45% growth in the latest year. EBITDA rose 368% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bicardia Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bicardia Pharmaceuticals Private Limited
Bicardia Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rachna Yadav | Director | 28 Nov 2019 | 6 Years 11 Months | Current |
| Avdhesh Kumar Yadav | Director | 21 Jun 2025 | 1 Years 4 Months | Current |
Peer comparison
Bicardia Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rishi Colonisers Private Limited | ₹1.52 Cr (FY 2024) | -66.0% | Lucknow, Uttar Pradesh, India | |||
| Surjeet Health Care Private Limited | ₹1.51 Cr (FY 2024) | 380.0% | Kanpur, Uttar Pradesh, India | |||
| KPL Life Science Private Limited | ₹1.51 Cr (FY 2025) | 10.0% | Surat, Gujarat, India | |||
| Anjola Biotec Private Limited | ₹1.51 Cr (FY 2022) | 64.0% | Hyderabad, Telangana, India | |||
| Bicardia Pharmaceuticals Private Limitedthis company | ₹1.51 Cr (FY 2025) | ₹2.37 Lakh | 1.6% | 45.0% | Meerut, Uttar Pradesh, India | |
| Womb Laboratories Pvt.Ltd. | ₹1.51 Cr (FY 2025) | 15.0% | Santhal, Gujarat, India |
To see the full peer comparison of Bicardia Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bicardia Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bicardia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bicardia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAICB7733J1ZI | Uttarakhand | Active | 20 Feb 2020 |
To see the full GST registrations and return filing status of Bicardia Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bicardia Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Avdhesh Kumar Yadav was appointed as Director on 21 Jun 2025.
Frequently asked questions
Bicardia Pharmaceuticals is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 November 2019 (7+ years old) and is registered under CIN U24304UP2019PTC123940.
Bicardia Pharmaceuticals has 2 current directors:
- Rachna Yadav - Director
- Avdhesh Kumar Yadav - Director
The latest financial statements of Bicardia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Bicardia Pharmaceuticals is 05AAICB7733J1ZI, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Bicardia Pharmaceuticals is U24304UP2019PTC123940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bicardia Pharmaceuticals was incorporated on 28 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Bicardia Pharmaceuticals by revenue are Rishi Colonisers Private Limited, Surjeet Health Care Private Limited, KPL Life Science Private Limited, Anjola Biotec Private Limited, Womb Laboratories Pvt.Ltd, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Avdhesh Kumar Yadav was appointed as Director on 21 Jun 2025. Hema Pandey ceased to be Additional Director on 30 Sep 2022. Dharam Pal Singh ceased to be Director on 12 Sep 2022. Bicardia Pharmaceuticals has 4 board changes on record in total.
The registered office of Bicardia Pharmaceuticals is at CO Beena Devi WO Dharampal Singh Yadav Krishna Vihar Colony Bhoola Road, Meerut, Uttar Pradesh, India – 250002.
Bicardia Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Bicardia Pharmaceuticals can be reached at its registered office: CO Beena Devi WO Dharampal Singh Yadav Krishna Vihar Colony Bhoola Road, Meerut, Uttar Pradesh, India – 250002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
